chromosome 14q32
Recently Published Documents


TOTAL DOCUMENTS

28
(FIVE YEARS 1)

H-INDEX

14
(FIVE YEARS 0)

2021 ◽  
pp. 106665
Author(s):  
Rachel A. Harris ◽  
Jadd. M. Stevens ◽  
Diane L. Pickering ◽  
Pamela A. Althof ◽  
Lynette M. Smith ◽  
...  

2020 ◽  
Vol 29 (R1) ◽  
pp. R107-R116 ◽  
Author(s):  
Rexxi Prasasya ◽  
Kristen V Grotheer ◽  
Linda D Siracusa ◽  
Marisa S Bartolomei

Abstract Temple syndrome (TS) and Kagami-Ogata syndrome (KOS) are imprinting disorders caused by absence or overexpression of genes within a single imprinted cluster on human chromosome 14q32. TS most frequently arises from maternal UPD14 or epimutations/deletions on the paternal chromosome, whereas KOS most frequently arises from paternal UPD14 or epimutations/deletions on the maternal chromosome. In this review, we describe the clinical symptoms and genetic/epigenetic features of this imprinted region. The locus encompasses paternally expressed protein-coding genes (DLK1, RTL1 and DIO3) and maternally expressed lncRNAs (MEG3/GTL2, RTL1as and MEG8), as well as numerous miRNAs and snoRNAs. Control of expression is complex, with three differentially methylated regions regulating germline, placental and tissue-specific transcription. The strong conserved synteny between mouse chromosome 12aF1 and human chromosome 14q32 has enabled the use of mouse models to elucidate imprinting mechanisms and decipher the contribution of genes to the symptoms of TS and KOS. In this review, we describe relevant mouse models and highlight their value to better inform treatment options for long-term management of TS and KOS patients.


2019 ◽  
Vol 44 (4) ◽  
pp. 487-491 ◽  
Author(s):  
Hani Alsaadoni ◽  
Burcu Çaykara ◽  
Sadrettin Pençe ◽  
Halime Hanım Pençe ◽  
Süleyman Bademler

Abstract Background Gastric cancer, one of the most common cancers in the world, is a multifactorial disease in which environmental and genetic factors play a role. In our study, we aimed to determine the expression levels of four miRNAs (miR127-5p, miR-544a, miR-369-3p and miR-655-3p) on chromosome 14q32 in gastric cancer. Materials and methods Total RNA was isolated from blood samples taken from 66 gastric cancer and 66 healthy individuals. The gene expression levels determined by cDNA and quantitative real-time polymerase chain reaction were analyzed according to the 2−∆∆Ct method. SPSS 22 were used for statistical analysis and p < 0.05 was considered as statistically significant. Results and discussion miR-655-3p (fold change: 100, p = 0.026), miR-127-5p (fold change: 48, p < 0.001) and miR-369-3p (fold change: 1.6, p > 0.05) was less expressed in the gastric cancer group than control group. miR-544a was found 15.5-fold more expressed in the patient group than control group (fold change: 15.47, p < 0.001). Conclusion miR127-5p, miR-544a, and miR-655-3p may be evaluated as biomarkers in gastric cancer.


Leukemia ◽  
2018 ◽  
Vol 32 (12) ◽  
pp. 2720-2723 ◽  
Author(s):  
Daria V. Babushok ◽  
Natasha L. Stanley ◽  
Jennifer J. D. Morrissette ◽  
David B. Lieberman ◽  
Timothy S. Olson ◽  
...  

2018 ◽  
Vol 16 (3) ◽  
pp. 390-402 ◽  
Author(s):  
Margarita González-Vallinas ◽  
Manuel Rodríguez-Paredes ◽  
Marco Albrecht ◽  
Carsten Sticht ◽  
Damian Stichel ◽  
...  

Reproduction ◽  
2015 ◽  
Vol 149 (5) ◽  
pp. R237-R249 ◽  
Author(s):  
Mark Howard ◽  
Marika Charalambous

Uniparental inheritance of chromosome 14q32 causes developmental failure during gestation and early postnatal development due to mis-expression of a cluster of imprinted genes under common epigenetic control. Two syndromes associated with chromosome 14q32 abnormalities have been described, Kagami–Ogata and Temple syndromes. Both of these syndromes are characterised by specific impairments of intrauterine development, placentation and early postnatal survival. Such abnormalities arise because the processes of intrauterine growth and postnatal adaptation are critically modulated by the dosage of imprinted genes in the chromosome 14q32 cluster. Much of our understanding of how the imprinted genes in this cluster are regulated, as well as their individual functions in the molecular pathways controlling growth and postnatal adaptation, has come from murine models. Mouse chromosome 12qF1 contains an imprinted region syntenic to human chromosome 14q32, collectively referred to as the Dlk1–Dio3 cluster. In this review, we will summarise the wealth of information derived from animal models of chromosome 12 imprinted gene mis-regulation, and explore the relationship between the functions of individual genes and the phenotypic result of their mis-expression. As there is often a considerable overlap between the functions of genes in the Dlk1–Dio3 cluster, we propose that the expression dosage of these genes is controlled by common regulatory mechanisms to co-ordinate the timing of growth and postnatal adaptation. While the diseases associated with mis-regulated chromosome 14 imprinting are rare, studies carried out in mice on the functions of the affected genes as well as their normal regulatory mechanisms have revealed new mechanistic pathways for the control of growth and survival in early life.


2014 ◽  
Vol 2014 ◽  
pp. 1-16 ◽  
Author(s):  
Steven M. Prideaux ◽  
Emma Conway O'Brien ◽  
Timothy J. Chevassut

Multiple myeloma is a malignant proliferation of monoclonal plasma cells leading to clinical features that include hypercalcaemia, renal dysfunction, anaemia, and bone disease (frequently referred to by the acronym CRAB) which represent evidence of end organ failure. Recent evidence has revealed myeloma to be a highly heterogeneous disease composed of multiple molecularly-defined subtypes each with varying clinicopathological features and disease outcomes. The major division within myeloma is between hyperdiploid and nonhyperdiploid subtypes. In this division, hyperdiploid myeloma is characterised by trisomies of certain odd numbered chromosomes, namely, 3, 5, 7, 9, 11, 15, 19, and 21 whereas nonhyperdiploid myeloma is characterised by translocations of the immunoglobulin heavy chain alleles at chromosome 14q32 with various partner chromosomes, the most important of which being 4, 6, 11, 16, and 20. Hyperdiploid and nonhyperdiploid changes appear to represent early or even initiating mutagenic events that are subsequently followed by secondary aberrations including copy number abnormalities, additional translocations, mutations, and epigenetic modifications which lead to plasma cell immortalisation and disease progression. The following review provides a comprehensive coverage of the genetic and epigenetic events contributing to the initiation and progression of multiple myeloma and where possible these abnormalities have been linked to disease prognosis.


2012 ◽  
Vol 3 (4) ◽  
pp. 677-682 ◽  
Author(s):  
ERIC J. DEVOR ◽  
JILLIAN N. DE MIK ◽  
SHYAM RAMACHANDRAN ◽  
MICHAEL J. GOODHEART ◽  
KIMBERLY K. LESLIE

Sign in / Sign up

Export Citation Format

Share Document